Cherry Masangkay

The Arable mission is to reduce the costs of biomedical technology, products, services, R&D while enabling a new era of personalized medicine improving quality of life through the early detection, treatment & understanding of disease & how to prevent it. • Nanotechnology based live cell quantitative analytical platform • LED-­‐based phototherapy (low‐level light therapy) combatting illness, treating injury and immune system boosting Arable’s nano cytology promises “quantitative” rapid detection of cancer minutes versus days. AraLight phototherapy treatments available as “rapid response” to patients suffering from illness, recovering from injury, undergoing cancer therapies, seeking to strengthen natural immune system. Phototherapy treats diseases like diabetes, arthritis, severe trauma (concussion & traumatic brain injury), minimizes debilitating impact of cancer therapy. Arable’s technology is enabling the timely & cost efficient development of new drugs. Arable’s suite of technologies: • Early & quantitatively meaningful cancer detection, staging, and monitoring • AraLight phototherapy to minimize distress & discomfort of radiation or chemotherapy treatment while supporting immune system recovery